Skip to content

Duration of perioperative antibiotic prophylaxis in patients undergoing pancreatoduodenectomy

Duration of perioperative antibiotic prophylaxis in patients undergoing pancreatoduodenectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0010667
Enrollment
558
Registered
2025-06-23
Start date
2025-06-30
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Adult men and women between the ages of 18 and 80 who are scheduled to undergo pancreatic duodenal resection 2. A person who voluntarily decides to participate after hearing sufficient explanation for this clinical trial and agrees in writing

Exclusion criteria

Exclusion criteria: 1. A history of type 1 immediate hypersensitivity reactions to cefazolin or cefotaxime or metronidazole 2. If treatment is not completed for preoperative active or uncontrolled infections 3. If antibiotics were taken for any reason within a week prior to surgery 4. If you are taking immunosuppressants for a long time due to other comorbidities 5. During dialysis or if you have KDIGO Grade 3 or higher renal dysfunction (GFR <45) 6. Pregnancy or lactation

Design outcomes

Primary

MeasureTime frame
Incidence of surgical site infection

Secondary

MeasureTime frame
Adverse Event, AE

Countries

Korea, Republic of

Contacts

Public ContactSung-Han Kim

Asan Medical Center

shkimmd@amc.seoul.kr+82-2-3010-3305

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026